BDBM742451 N-[3-[2-cyano-4- methyl-5-[[2-[6-(2,2,2- trifluoroethyl) quinazolin-4-yl]-2,7- diazaspiro[3.5]nonan- 7-yl]methyl]indol-1- yl]methyl]-1-bicyclo [1.1.1]pentanyl] acetamide Example 60::US20250163061, Compound 59

SMILES CC(=O)NC12CC(Cn3c(C#N)cc4c(C)c(CN5CCC6(CC5)CN(c5ncnc7ccc(CC(F)(F)F)cc57)C6)ccc43)(C1)C2

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 742451   

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742451(N-[3-[2-cyano-4- methyl-5-[[2-[6-(2,2,2- trifluoro...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent